Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana [Corrigendum]

Abstract

Maseng MJ, Tawe L, Thami PK, et al. Pharmgenomics Pers Med. 2021;14:335–347. The authors have advised that there is an error in Table 6 on page 342. The reference “39” in the third row for the References column should read “41”. The authors apologize for this error. Read the original article

Keywords

• art
• cyp2b6 gene
• drug resistance selection
• fast metabolizers
• hiv